THE ESTROGEN DILEMMA

AMERICA'S NO. 1 DRUG IS AN ELIXIER OF YOUTH, BUT WOMEN MUST DECIDE IF IT'S WORTH THE RISK OF CANCER

On Feb. 13, 1963, a new patient strode into the office of New York City gynecologist Robert A. Wilson. To Wilson, she was nothing less than a revelation or, to be more precise, a walking, talking confirmation of his most deeply held medical convictions. Wilson was a leading proponent of treating menopausal women with the female hormone estrogen. He was convinced that, given early enough and continued throughout life, hormone treatment could actually prevent what he called the "staggering catastrophe" of menopause and the "fast and painful aging process" that attended it.

Wilson's new patient, "Mrs. P.G.," as he later called...

Want the full story?

Subscribe Now

Subscribe
Subscribe

Get TIME the way you want it

  • One Week Digital Pass — $4.99
  • Monthly Pay-As-You-Go DIGITAL ACCESS$2.99
  • One Year ALL ACCESSJust $30!   Best Deal!
    Print Magazine + Digital Edition + Subscriber-only Content on TIME.com

Learn more about the benefits of being a TIME subscriber

If you are already a subscriber sign up — registration is free!